DH82 Dog Kidney Malignant Histiocytosis Cell

It was taken from a 10-year-old male dog. DH82 cells have macrophage-like morphology and can phagocytic latex particles. The cells have Fcgamma receptor positive, Fcmu and C3b receptor negative. Cells do not produce IL-1. It was put into storage after identification without mycoplasma.

Animal species/Organism male dog

Tissue and Cell Type kidney, malignant histiocytosis cells

Morphology macrophages, adherent growth

Culture media and additives/Complete Growth Medium and Culture Conditions:

90% MEM (MD0300)+10% fetal bovine serum (SD0200)+G/A (SD0038)

Complete medium: MEM complete medium (article number: MD0301)

Gas phase: air, 95%; Carbon dioxide, 5%. Temperature: 37 ℃.

Freezing conditions: basic medium+5% DMSO+20% FBS (SD0200)

Complete cryopreservation solution: non-programmed cooling cell cryopreservation solution (low serum) (SD0001)

Note: This product is for scientific research only

PubMed=3350786; DOI=10.1007/BF02623551

Wellman M.L., Krakowka S., Jacobs R.M., Kociba G.J.

A macrophage-monocyte cell line from a dog with malignant histiocytosis.

In Vitro Cell. Dev. Biol. 24:223-229(1988)

PubMed=21908323; DOI=10.1177/1040638711408064

O'Donoghue L.E., Rivest J.P., Duval D.L.

Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation.

J. Vet. Diagn. Invest. 23:780-785(2011)

PubMed=25534080; DOI=10.1016/j.vetimm.2014.11.006

Heinrich F., Contioso V.B., Stein V.M., Carlson R., Tipold A., Ulrich R., Puff C., Baumgartner W., Spitzbarth I.

Passage-dependent morphological and phenotypical changes of a canine histiocytic sarcoma cell line (DH82 cells).

Vet. Immunol. Immunopathol. 163:86-92(2015)

PubMed=27257868; DOI=10.1371/journal.pone.0156689

Maeda J., Froning C.E., Brents C.A., Rose B.J., Thamm D.H., Kato T.A.

Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.

PLoS ONE 11:E0156689-E0156689(2016)

PubMed=26842912; DOI=10.1111/vco.12197

Hartley G., Faulhaber E., Caldwell A., Coy J., Kurihara J., Guth A., Regan D., Dow S.

Immune regulation of canine tumour and macrophage PD-L1 expression.

Vet. Comp. Oncol. 15:534-549(2017)

PubMed=27197945; DOI=10.1111/vco.12192

Fowles J.S., Dailey D.D., Gustafson D.L., Thamm D.H., Duval D.L.

The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.

Vet. Comp. Oncol. 15:481-492(2017)

PubMed=28620374; DOI=10.3389/fimmu.2017.00604

Mendonca P.H.B., da Rocha R.F.D.B., Moraes J.B.B., LaRocque-de-Freitas I.F., Logullo J., Morrot A., Nunes M.P., Freire-de-Lima C.G., Decote-Ricardo D.

Canine macrophage DH82 cell line as a model to study susceptibility to Trypanosoma cruzi infection.

Front. Immunol. 8:604-604(2017)

PubMed=31175136; DOI=10.1158/1535-7163.MCT-18-1346

Das S., Idate R., Cronise K.E., Gustafson D.L., Duval D.L.

Identifying candidate druggable targets in canine cancer cell lines using whole exome sequencing.

Mol. Cancer Ther. 18:1460-1471(2019)